ストックスクリーナーアプリを入手
141.65
2.51%
-3.65
アフターアワーズ：
141.90
0.25
+0.18%
Illumina Inc (ILMN) 最新ニュース
Global Pan-Genomic and Multi-Gene Panel Testing Market Forecast to Hit US$ 25.91 Billion by 2032 at 12.04% CAGR, Driven by Growing Demand for Comprehensive Multi-Gene Diagnostics: AnalystView Market Insights - GlobeNewswire Inc.
Oncology Research Solutions - Illumina
Illumina partners with pharma giants to map disease biology at unprecedented scale - Mugglehead Magazine
2026: A turning point for precision health - Illumina
Illumina's new connected multiomics platform set to boost its stock - MSN
Sumitomo Mitsui Trust Group Inc. Acquires 54,987 Shares of Illumina, Inc. $ILMN - MarketBeat
Illumina reports 5% revenue growth in Q4 2025, flat for full year - Investing.com Nigeria
Illumina launches billion cell atlas to boost AI-driven drug discovery - Investing.com Nigeria
Illumina Launches Billion Cell Atlas to Accelerate AI-Driven Drug Development - filmogaz.com
Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery - The Malaysian Reserve
Illumina CEO Sees Big Growth Opportunity in China - marketscreener.com
Illumina Announces Alliance Framework with AstraZeneca, Merck, and Eli Lilly and Company - marketscreener.com
JPM26: Illumina debuts Billion Cell Atlas to drive AI-driven drug discovery - Pharmaceutical Technology
Illumina Produces Midteens Earnings Growth in 2025, Distancing Itself From the Grail Debacle - morningstar.com
Canada Next-Generation Sequencing (NGS) Market Analysis and Forecast, 2025-2035, Featuring Illumina, Oxford Nanopore Technologies, Pacific Bioscience of California, MGI Tech Co., QIAGEN and More - GlobeNewswire
Illumina (NASDAQ:ILMN) Updates Q4 2025 Earnings Guidance - MarketBeat
Illumina introduces Billion Cell Atlas, genome-wide genetic perturbation dataset - marketscreener.com
Illumina Billion Cell Atlas to accelerate AI, drug discovery - BioWorld MedTech
Illumina Introduces Illumina Billion Cell Atlas To Accelerate AI Drug Discovery - Nasdaq
Illumina unveils dataset to speed up AI-powered drug discovery - Reuters
Illumina introduces billion cell atlas to accelerate AI and drug discovery - marketscreener.com
Illumina Introduces Genetic Perturbation Dataset to Further AI Drug Discovery - marketscreener.com
Illumina Preliminary Q4, Annual Results Beat Analysts' View - Nasdaq
Illumina Reports Preliminary Fiscal Q4 Non-GAAP Earnings, Revenue - marketscreener.com
(ILMN) Illumina Expects 2025 Revenue About $4.34B, vs. FactSet Est of $4.28B - marketscreener.com
Illumina reports preliminary Q4 revenue of $1.15B - MSN
Illumina Announces Preliminary Unaudited Financial Results for Q4 and Fiscal Year 2025 - TradingView — Track All Markets
Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025 - PR Newswire
Illumina launches massive cell atlas to fast-track drug discovery - statnews.com
Assessing Illumina (ILMN) Valuation After New Multiomics Platform And Chief Medical Officer Appointment - Yahoo Finance
DNA Methylation Sequencing Market Set to Revolutionize - openPR.com
Illumina and PREMIA partner to expand clinical access to CGP in Asia - ANTARA News
Dr Eric Green named Illumina Chief Medical Officer - Medical Buyer
Illumina, Inc. (ILMN): A Closer Look At Its Growth Potential Amidst Analyst Ratings - DirectorsTalk Interviews
Illumina to Announce Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 5, 2026 - WV News
Illumina names former NIH genomics director as chief medical officer - MedTech Dive
Illumina's New Connected Multiomics Platform Set to Boost Its Stock - The Globe and Mail
How Is The Market Feeling About Illumina Inc? - Benzinga
Hardman Johnston Global Advisors LLC Has $14.95 Million Stock Position in Illumina, Inc. $ILMN - MarketBeat
SG Americas Securities LLC Buys 53,795 Shares of Illumina, Inc. $ILMN - MarketBeat
Cerity Partners LLC Increases Stock Position in Illumina, Inc. $ILMN - MarketBeat
Cathie Wood’s ARK ETF Buys Intellia, Personalised Stock; Sells Illumina By Investing.com - Investing.com Canada
Cathie Wood’s ARK ETF Buys Intellia, Personalised Stock; Sells Illumina - Investing.com
Illumina Inc. Stock Underperforms Friday When Compared To Competitors - 富途牛牛
Will Illumina (ILMN) Beat Estimates Again in Its Next Earnings Report? - sharewise.com
Illumina names former NIH official as medical chief; commercial chief joins Quanterix - Seeking Alpha
Former NIH genomics director Eric Green to join Illumina as CMO - statnews.com
Precision Trading with Illumina Inc. (ILMN) Risk Zones - Stock Traders Daily
Will Illumina Inc. stock split again soon2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - ulpravda.ru
Can Illumina Inc. stock sustain revenue growthQuarterly Profit Review & Long-Term Safe Return Strategies - ulpravda.ru
Illumina Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Is Illumina Inc ILU stock a momentum leaderJuly 2025 Big Picture & Fast Gaining Stock Strategy Reports - moha.gov.vn
What makes Illumina Inc. (ILU) stock appealing to growth investorsJuly 2025 Recap & Weekly Momentum Picks - ulpravda.ru
Illumina Appoints Dr. Eric Green as Chief Medical Officer - Illumina
Is It Time To Reassess Illumina (ILMN) After Its Recent Share Price Rebound - Yahoo Finance
0.74%
1.83%
大文字化:
|
ボリューム (24 時間):